Article

Redox Modification of Nuclear Actin by MICAL-2 Regulates SRF Signaling.

Cell (Impact Factor: 31.96). 01/2014; DOI: 10.1016/j.cell.2013.12.035
Source: PubMed

ABSTRACT The serum response factor (SRF) binds to coactivators, such as myocardin-related transcription factor-A (MRTF-A), and mediates gene transcription elicited by diverse signaling pathways. SRF/MRTF-A-dependent gene transcription is activated when nuclear MRTF-A levels increase, enabling the formation of transcriptionally active SRF/MRTF-A complexes. The level of nuclear MRTF-A is regulated by nuclear G-actin, which binds to MRTF-A and promotes its nuclear export. However, pathways that regulate nuclear actin levels are poorly understood. Here, we show that MICAL-2, an atypical actin-regulatory protein, mediates SRF/MRTF-A-dependent gene transcription elicited by nerve growth factor and serum. MICAL-2 induces redox-dependent depolymerization of nuclear actin, which decreases nuclear G-actin and increases MRTF-A in the nucleus. Furthermore, we show that MICAL-2 is a target of CCG-1423, a small molecule inhibitor of SRF/MRTF-A-dependent transcription that exhibits efficacy in various preclinical disease models. These data identify redox modification of nuclear actin as a regulatory switch that mediates SRF/MRTF-A-dependent gene transcription.

1 Bookmark
 · 
71 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Oxidative stress has long been implicated in cardiovascular disease, but more recently, the role of reactive oxygen species (ROS) in normal physiological signaling has been elucidated. Signaling pathways modulated by ROS are complex and compartmentalized, and we are only beginning to identify the molecular modifications of specific targets. Here, we review the current literature on ROS signaling in the cardiovascular system, focusing on the role of ROS in normal physiology and how dysregulation of signaling circuits contributes to cardiovascular diseases, including atherosclerosis, ischemia-reperfusion injury, cardiomyopathy, and heart failure. In particular, we consider how ROS modulate signaling pathways related to phenotypic modulation, migration and adhesion, contractility, proliferation and hypertrophy, angiogenesis, endoplasmic reticulum stress, apoptosis, and senescence. Understanding the specific targets of ROS may guide the development of the next generation of ROS-modifying therapies to reduce morbidity and mortality associated with oxidative stress. © 2015 American Heart Association, Inc.
    Circulation Research 01/2015; 116(3):531-549. DOI:10.1161/CIRCRESAHA.116.303584 · 11.09 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Redox signalling regulates numerous aspects of cytoskeletal dynamics•Specific redox modification of Cys and Met residues controls actin dynamics•Various molecules controlling cytoskeltal dynamics are redox regulated
    Biochimica et Biophysica Acta (BBA) - General Subjects 11/2014; DOI:10.1016/j.bbagen.2014.10.030 · 3.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Skeletal muscle atrophy is a debilitating process associated with a wide variety of conditions including inactivity, disease and aging. Here, we demonstrate that the actin/Mrtfs/Srf pathway is specifically downregulated in muscle atrophy induced by disuse in mice. We show in vivo that the abolition of mechanical signals leads to rapid accumulation of G-actin in myonuclei and export of the Srf coactivator Mrtf-A, resulting in Mrtfs/Srf-dependent transcription decrease that contributes to atrophy. We demonstrate that inhibition of the actin/Mrtfs/Srf axis by overexpression of nuclear non-polymerizable actin, pharmacological inhibition of Mrtfs/Srf and muscle-specific Srf deletion worsens denervation-induced atrophy. Conversely, maintenance of high Srf or Mrtfs activity in denervated muscle, through overexpression of constitutively active derivatives, counteracts atrophy. Altogether, our data provide new mechanistic insights into the control of muscle mass upon disuse atrophy by the actin/Mrtfs/Srf pathway, highlighting Srf as a key mediator of mechanotransduction in muscle.
    Journal of Cell Science 10/2014; DOI:10.1242/jcs.155911 · 5.33 Impact Factor